Athos Therapeutics, Inc.
Pharmaceuticals · TORRANCE, CA
PharmaceuticalsSEC Form D
Athos Therapeutics, Inc. filed a Form D with the U.S. Securities and Exchange Commission on May 15, 2026, reporting $10,282,887 raised toward a $20,000,000 offering.
Incorporated in Delaware and based in TORRANCE, CA, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Athos Therapeutics, Inc. has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- Dimitrios IliopoulosExecutive Officer · Director
- Allan J. PantuckExecutive Officer · Director
- Carl McKinzieDirector
- Joel CohenDirector
- Anthony ZingaleDirector
- Laurence SteinDirector
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$50.0KRaised
Matthias Therapeutics, LLC
$5.3MRaised
GridAI Technologies Corp.
$2.5MRaised
GridAI Technologies Corp.
$22.5MRaised
CNS Pharmaceuticals, Inc.
$4.9MRaised